Browse every story filed under this topic, curated from trusted publishers around the world.
Novo Nordisk is set to launch Ozempic, its oral GLP-1 receptor agonist pill for adults with type 2 diabetes, in the US.
Read full story →
Danco Laboratories, one of makers of the mifepristone abortion pill on Saturday asked the Supreme Court to pause a lower …
A pharmaceutical company that manufactures and distributes the abortion pill Mifepristone asked the Supreme Court on Saturday to block a …
A federal appeals court shut off telehealth access Friday.
Democrats are pushing back on a recent court ruling that blocked doctors’ ability to prescribe the abortion pill mifepristone through …
A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by …
Mifepristone, involved in most abortions in the U.S., can now be distributed only in person and at clinics.
A federal appeals court on Friday granted the state of Louisiana's request to reinstate a nationwide requirement that abortion pills …
A federal appeals court late Friday blocked the ability of doctors to prescribe the abortion pill mifepristone through telehealth and …
The temporary ruling will curtail access nationwide to a drug used in more than two-thirds of abortions.
What You Should Know GoodRx has launched access to self-pay pricing for Novo Nordisk’s Ozempic® pill (oral semaglutide) for patients …
Axsome Therapeutics’ Auvelity expanded its label to include treating agitation in Alzheimer’s disease patients. It’s just the second FDA-approved drug …
Tom Lowery has already swallowed the bitter pill of relegation once in his career and doesn't want to taste it …
The semaglutide franchise is changing up its branding as Novo Nordisk, seeing the cultural phenomenon that has become Ozempic, is …
As Eli Lilly gets off to the races with the launch of its flagship oral GLP-1 Foundayo, the Indianapolis drugmaker—and …
Chiesi will assume ownership of Ekterly, an on-demand pill approved for hereditary angioedema.
Coultreon Biopharma’s lead drug candidate, acquired from Galapagos, is a small molecule designed to selectively inhibit a novel immunology target …
Eli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and more biotech news today
Veradermics' VDPHL01, an oral version of the existing drug minoxidil, showed strong results in a late stage clinical trial.
The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer …
You've seen all articles for #pills.
Check back
soon
for new stories.